Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Feb 2, 2010

Premium

CombiMatrix has tapped Mark McGowan to serve on its board of directors. McGowan is the managing member of SAF Capital Management, and he co-founded and served as managing partner of MPG Capital Management.


Mike Hoerres has joined Geisinger Ventures as a principal. Ventures is Geisinger Health System's for-profit venture arm.

Prior to joining Geisinger, Hoerres was vice president of business development at Source MDx. He also served previously as clinical market development manager at Affymetrix and director of business development at Incyte Genomics.


Sequenom has appointed Wolfgang Holzgreve to its clinical advisory board. Holzgreve currently is director and chairman of the board of directors at the University Hospital Freiburg, Germany, and he formerly was chairman of the department and chief of service at the department of obstetrics and gynecology at the University of Basel.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.